74 related articles for article (PubMed ID: 8731830)
21. Randomized, double-blind, controlled study of cefoperazone-sulbactam plus cotrimoxazole versus ceftazidime plus cotrimoxazole for the treatment of severe melioidosis.
Chetchotisakd P; Porramatikul S; Mootsikapun P; Anunnatsiri S; Thinkhamrop B
Clin Infect Dis; 2001 Jul; 33(1):29-34. PubMed ID: 11389491
[TBL] [Abstract][Full Text] [Related]
22. Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model.
Moody JA; Fasching CE; Sinn LM; Gerding DN; Peterson LR
J Lab Clin Med; 1990 Feb; 115(2):190-5. PubMed ID: 1967626
[TBL] [Abstract][Full Text] [Related]
23. Cefoperazone/sulbactam + co-trimoxazole vs ceftazidime + co-trimoxazole in the treatment of severe melioidosis: a randomized, double-blind, controlled study.
Thamprajamchit S; Chetchotisakd P; Thinkhamrop B
J Med Assoc Thai; 1998 Apr; 81(4):265-71. PubMed ID: 9623020
[TBL] [Abstract][Full Text] [Related]
24. [Comparison of efficacy between ceftriaxone and cefoperazone plus sulbactam in peri-operative treatment of acute suppurative cholangitis].
Zhou XS; Zou SQ; Dong JH; Wu WZ; Zhang YD; Zhang TL; Zeng Z; Li NF; Man GT
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1879-82. PubMed ID: 15631798
[TBL] [Abstract][Full Text] [Related]
25. Sulbactam/ampicillin versus cefotaxime as initial therapy in serious soft tissue, joint and bone infections.
Löffler L; Bauernfeind A; Keyl W
Drugs; 1988; 35 Suppl 7():46-52. PubMed ID: 3265378
[TBL] [Abstract][Full Text] [Related]
26. [In vitro antibacterial activity of sulperazone on multi-resistant strains of bacteria from burn wounds].
Xu W; Chen X
Zhonghua Wai Ke Za Zhi; 1995 Jul; 33(7):390-2. PubMed ID: 8565723
[TBL] [Abstract][Full Text] [Related]
27. Cefoperazone-sulbactam combination in the treatment of urinary tract infections: efficacy, safety, and effects on coagulation.
Greenberg RN; Reilly PM; Weinandt WJ; Bollinger M; Kennedy DJ
Clin Ther; 1987; 10(1):52-6. PubMed ID: 3329965
[TBL] [Abstract][Full Text] [Related]
28. Ceftizoxime vs. cefotaxime--a comparative randomized multicenter study.
Segev S; Kitzes R; Rubinstein E; Pitlik S; Samra Y; Shenkman L; Weinberg M
Isr J Med Sci; 1988 Aug; 24(8):410-4. PubMed ID: 3045049
[TBL] [Abstract][Full Text] [Related]
29. A randomized clinical study of cefoperazone and sulbactam versus gentamicin and clindamycin in the treatment of intra-abdominal infections.
Jauregui LE; Appelbaum PC; Fabian TC; Hageage G; Strausbaugh L; Martin LF
J Antimicrob Chemother; 1990 Mar; 25(3):423-33. PubMed ID: 2187014
[TBL] [Abstract][Full Text] [Related]
30. Cefoperazone/sulbactam therapeutic drug monitoring in patients with liver cirrhosis: Potential factors affecting the pharmacokinetic/pharmacodynamic target attainment.
Dong Y; Li Y; Zhang Y; Zhang T; Zhu L; Dong Y; Wang T
Basic Clin Pharmacol Toxicol; 2019 Oct; 125(4):353-359. PubMed ID: 31056857
[TBL] [Abstract][Full Text] [Related]
31. Clinical evaluation of cefotaxime versus gentamicin plus clindamycin in the treatment of polymicrobial peritonitis.
Stone HH; Geheber CE; Kolb LD; Strom PR
Clin Ther; 1982; 5 Suppl A():1-9. PubMed ID: 6293712
[TBL] [Abstract][Full Text] [Related]
32. Sulbactam-containing beta-lactamase inhibitor combinations.
Akova M
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():185-8. PubMed ID: 18154545
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of cefoperazone in the treatment of bacterial infections in patients with hematological diseases.
Ichimaru M; Takatsuki K; Niho Y; Sawae Y
Clin Ther; 1984; 7(1):60-8. PubMed ID: 6518464
[TBL] [Abstract][Full Text] [Related]
34. Comparative in vitro and in vivo activity of cefminox (MT-141), cefotaxime and cefoperazone against gram-negative bacteria.
Watanabe T; Kazuno Y; Hirano F; Inouye S; Nishino T
Drugs Exp Clin Res; 1985; 11(11):781-6. PubMed ID: 3841789
[TBL] [Abstract][Full Text] [Related]
35. Effect of formulary restriction of cefotaxime usage.
DeVito JM; John JF
Arch Intern Med; 1985 Jun; 145(6):1053-6. PubMed ID: 4004430
[TBL] [Abstract][Full Text] [Related]
36. A study of cefotaxime versus netilmicin versus netilmicin and cefotaxime in serious infections.
Sen RA; Keaney MG; Ganguli LA
J Chemother; 1989 Jul; 1(4 Suppl):652-4. PubMed ID: 16312576
[No Abstract] [Full Text] [Related]
37. Cefotaxime in the treatment of lower respiratory tract infections.
Beumer HM; Veldkamp J; Deleers L
Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):605-10. PubMed ID: 6321367
[TBL] [Abstract][Full Text] [Related]
38. [Antibacterial activity in vitro and clinical use of sulperazon].
Wang X; Shi Y; Qin W
Zhonghua Nei Ke Za Zhi; 1997 Jun; 36(6):406-10. PubMed ID: 10374302
[TBL] [Abstract][Full Text] [Related]
39. Clinical efficacy of cefotaxime in two different periods.
Peralta S; Vitale B; Scarsi C; D'Aiello G; Rotondo G; Delle Vedove G; Rini GB
J Chemother; 1989 Jul; 1(4 Suppl):648-9. PubMed ID: 16312574
[No Abstract] [Full Text] [Related]
40. [Comparison between cefoperazone and cefotaxime in the treatment of infections of the lower respiratory tract].
Fantoni U; Ruffilli MP; Ecari U
Clin Ter; 1987 May; 121(3):209-12. PubMed ID: 2956011
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
